1. Inhibition of thymidylate synthase affects neural tube development in mice
   Xiuwei Wang et al, 2018, Reproductive Toxicology CrossRef
2. FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
   Meng Xie et al, 2023, Journal of Hepatology CrossRef
3. Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
   Kai Hung Tiong et al, 2016, Oncotarget CrossRef
4. Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study
   Faisal Aziz et al, 2015, Journal of Cancer Research and Clinical Oncology CrossRef
5. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer
   Hao Chen, 2015, World Journal of Gastroenterology CrossRef
6. FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma
   Koos Koole et al, 2015, Pathobiology CrossRef
7. A novel cell membrane affinity sample pretreatment technique for recognition and preconcentration of active components from traditional Chinese medicine
   Yusi Bu et al, 2017, Scientific Reports CrossRef
8. Making way for suppressing the FGF19/FGFR4 axis in cancer
   Nestor Prieto-Dominguez et al, 2018, Future Medicinal Chemistry CrossRef
9. FGFR and inhibitors
   Xiaokun Li, 2024, Fibroblast Growth Factors CrossRef
10. A novel small molecule RK-019 inhibits FGFR2-amplification gastric cancer cell proliferation and induces apoptosis in vitro and in vivo
    Jun Zeng et al, 2022, Frontiers in Pharmacology CrossRef
11. Ginsenoside Rg3 induces FUT4-mediated apoptosis in H. pylori CagA-treated gastric cancer cells by regulating SP1 and HSF1 expressions
    Faisal Aziz et al, 2016, Toxicology in Vitro CrossRef
12. BLU-554, A selective inhibitor of FGFR4, exhibits anti-tumour activity against gastric cancer in vitro
    Xiangjian Zhang et al, 2022, Biochemical and Biophysical Research Communications CrossRef
13. FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer
    Norihiko Sasaki et al, 2020, Cancers CrossRef
14. TC-1 Overexpression Promotes Cell Proliferation in Human Non-Small Cell Lung Cancer that Can Be Inhibited by PD173074
    Jie Lei et al, 2014, PLoS ONE CrossRef
15. FGF‐1/‐3/FGFR4 signaling in cancer‐associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP‐7
    Yu‐Pan Bai et al, 2015, Cancer Science CrossRef
16. Partners in crime: The Lewis Y antigen and fucosyltransferase IV in Helicobacter pylori-induced gastric cancer
    Faisal Aziz et al, 2022, Pharmacology & Therapeutics CrossRef
17. Antitumor effects and the underlying mechanism of licochalcone A combined with 5-fluorouracil in gastric cancer cells
    Xiaolin Lin et al, 2017, Oncology Letters CrossRef
18. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients
    Baoqing Chen et al, 2018, Cancer Biology & Therapy CrossRef
19. The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer
    Jingjing Li et al, 2016, Tumor Biology CrossRef
20. The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
    Hyun-Jeong Shim et al, 2016, Cancer Research and Treatment CrossRef
21. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving SRC Signaling in Gastric Cancer
    Xing Zhang et al, 2022, Gastroenterology CrossRef
22. DFG-out Mode of Inhibition by an Irreversible Type-1 Inhibitor Capable of Overcoming Gate-Keeper Mutations in FGF Receptors
    Zhifeng Huang et al, 2015, ACS Chemical Biology CrossRef